RecruitingNot ApplicableNCT05879159

Accelerated Recovery After MIS Hepatectomy (ARAMIS Hep) to Support Early Discharge for Patients Undergoing Minimally Invasive Liver Resection

Sponsor

M.D. Anderson Cancer Center

Enrollment

36 participants

Start Date

Oct 5, 2023

Study Type

INTERVENTIONAL

Conditions

To learn if an accelerated recovery program can shorten the length of hospital stay in patients having minimally invasive liver surgery.

Min Age: 18 Years

Tumor amenable to MIS Kawaguchi-Gayet grade I hepatectomy (see figure 1 below)
No evidence of cirrhosis (based on imaging, evidence of portal hypertension, clinical features, or laboratory results)
No significant cardiopulmonary disease that would prevent patients from undergoing MIS resection
Ability to stay within 50 miles of medical center for immediate postop period
Age of 18 years or above - because no adverse event data are currently available on enhanced recovery and early discharge after hepatic resection for patients <18 years of age, children are excluded from this study
Ability to understand and the willingness to sign a written informed consent document
Non-English-speaking patients are eligible for participation

Patients who will be excluded include those with:
Tumors NOT amenable to MIS Kawaguchi-Gayet grade I hepatectomy
Tumors not amenable to MIS or Robotic-assisted surgical resection
Evidence of Cirrhosis on imaging, clinically, or lab testing
Inability to stay within 50 miles of the Cancer Center in the immediate post-operative period
Age below 18 years
Inability to consent for trial/protocol
Patients who are pregnant